Phase II trials in the EORTC

European Journal of Cancer Part A

Volumn 33, Issue 9, 1997, Pages 1361-1363

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CANCER VACCINE; CYTOSTATIC AGENT; CYTOTOXIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; CANCER; CANCER CHEMOTHERAPY; CANCER RESEARCH; CLINICAL PROTOCOL; CLINICAL TRIAL; HUMAN; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RELAPSE; REVIEW; TREATMENT OUTCOME;

EID: 0030783042     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)90049-6     Document Type: Article

References (5)

1. I Tannock D Warr Non-randomized clinical trials of cancer chemotherapy: phase II or III? J Nad Cancer Inst 80 1988 800 801
2. EA Gehan The determination of the number of patients required in a follow-up trial of a new chemotherapeutic agent J Chron Dis 13 1961 346 353
3. R Simon Optimal two-stage designs for phase II clinical trials Controlled Clin Trials 10 1989 1 10
4. J Herson SK Carter Calibrated phase II clinical trials in oncology Stot Med 5 1986 441 447
5. PF Thall RM Simon EH Estey New statistical strategy for monitoring safety and efficacy in single arm clinical trials J Clin Oncol 14 1996 296 303